ロード中...
Genetic Polymorphism at Val(80) (rs700518) of the CYP19A1 Gene is Associated with Aromatase Inhibitor Associated Bone Loss in Women with ER (+) Breast Cancer
PURPOSE: Polymorphisms in the CYP19A1 (aromatase) gene have been reported to influence disease-free survival and the incidence of musculoskeletal complaints in patients taking aromatase inhibitors (AIs) for estrogen receptor positive (ER+) breast cancer. Bone loss and fractures are wellrecognized co...
保存先:
| 主要な著者: | , , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2013
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3966714/ https://ncbi.nlm.nih.gov/pubmed/23643682 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bone.2013.04.021 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|